Need help?

Businesses for Sale and Investment

Showing 1 - 14 of 23,042 Businesses for Sale and Investment. Buy or Invest in a Business. Listed by Direct Business Owners & Business Brokers.
Filters
 

Clinic Equity Stake For Sale in Amman, Jordan

Integrative medicine company with clinics, retail, e-commerce, and B2B products, seeking funds for growth.
Integrative medicine company offering clinics, retail, e-commerce, and B2B distribution. - Focus areas include chronic disease management, OTC treatments, healthy lifestyle support, immune boosters, and holistic care. - Serves ~17,000 clients yearly through a mix of direct services and product sales. - Operates 5 business models: integrative medicine clinic, beauty-focused clinic, two pharmacy retail outlets, e-commerce platform, and medical marketing division. - Retail and e-commerce catalog includes 1,500+ products sourced from 250+ brands. - Exclusive B2B portfolio features 10 proprietary products, distributed through medical marketing channels. - Products manufactured by trusted third-party partners to ensure quality and scalability. - Business currently growing at 18% annually. - Operates with a valid operations license.
Integrative medicine company with clinics, retail, e-commerce, and B2B products, seeking funds for growth.
7.3   Amman
Run Rate Sales
USD 1.18 million
EBITDA Margin
15 %
Partial Stake Sale
USD 500 K for 30%
Contact Business

Newly Established Bio Diagnostics Company Equity Stake For Sale in Dubai, UAE

World’s absolute first instant methanol detection test protecting travelers and consumers from methanol poisoning.
Our brand is the world’s first instant methanol detection test, designed to protect consumers from deadly counterfeit alcohol. Our rapid-detection strip provides a fast, portable, and affordable solution for travelers, bars, hotels, and government agencies. HQ: Planned Dubai launch for cost-effective operations, global scalability, and safety of transactions. Market opportunity: $60B+ counterfeit alcohol crisis worldwide (1,000s of people die from methanol poisoning each year! and there is no way to test the drinks) Revenue model: • Direct-to-consumer (DTC): Sold online (Amazon, TikTok Shop, website) through major online retailers worldwide. • Bulk B2B sales: Hotels, universities, hospitals, pharmacies, retailers, train stations, bars, duty-free retailers. Globally. • Licensing deals: Partnering with biotech firms & alcohol brands for distribution. Projected price: ~$19.99 per pack, we must aim to have a 70% margin. Projected sales growth: •Year 1: 50K units → $1M revenue. •Year 2: 250K units → $5M revenue. •Year 3: 1M+ units → $20M+ revenue. Exit strategy: Sell to a biotech or alcohol safety giant etc for $50M+ or license the technology for passive royalties. Promoter experience & business relationships: • Founder: Experienced entrepreneur with expertise in luxury branding, viral marketing, and scaling consumer products with the globally recognized superstars behind the previous brand I have developed. • Scientific & business team: Partnering with chemists & biotech advisors to ensure product reliability. • Distribution talks: Engaging bars, airlines, hotels, etc. • Investor network: Seeking 1-2 strategic investors to fund final development and global launch. This product is positioned to disrupt a billion-dollar problem and scale as the go-to alcohol safety brand worldwide. Some of the brightest minds in biotech and science will be on board. The product is not medicine and does not need to be FDA-approved as we will market it as a consumer product (like pregnancy tests). The product will deliver a 90% accuracy which is enough to save millions of lives. This is a once-in-a-lifetime opportunity and we are applying for patents already.
6.8   Dubai
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 1.15 Mn for 20%
Contact Business

Bio Diagnostics Company Equity Stake For Sale in Gurugram, India

Med-tech R&D company with a patented technology for early stage multi-cancer detection seeks investors.
The company has pioneered the first blood-based cancer detection tests capable of identifying up to 30 common cancers. - We have consistently focused on innovative solutions for early-stage cancer detection to significantly reduce cancer-related deaths. - The company employs an ingenious approach that combines cutting-edge experimental tools with the latest advancements in deep learning methodologies. - With the global rise in cancer incidence, annual cancer deaths have also increased significantly. - Most cancers are diagnosed at late stages due to the absence of early clinical symptoms, leading to poor prognosis. - Early detection of cancer can reduce mortality by up to 70%, yet no current methods accurately detect cancer at early stages. - We have leveraged this opportunity by developing a groundbreaking blood test that detects 30 cancers in both males and females. - Our product integrates molecular mapping of the physiological state with a deep learning platform to identify cancer-specific molecular signatures. - The test is a novel, non-invasive blood-based screening method capable of detecting cancers and identifying the tissue of origin from the same sample. - The 30 cancers detected represent about 90% of new cancer cases each year. - Our test has achieved an unmatched accuracy of over 98% for early-stage cancer detection. - This advancement can significantly reduce the global cancer mortality burden. - The company is in the process of commercializing the test. - The promoter have over 40+ years of experience in the industry. - Licenses include CIN, SSM and GST. We have also applied for a USFDA. We have applied to the DCGI (Drugs Controller General of India) for market approval in India. We will launch operations post the DCGI approval. - Our target audience includes hospitals in India and Singapore. - Our R&D headquarters are in Haryana, with global headquarters in Singapore. - We also maintain an office in Singapore with dedicated staff.
Med-tech R&D company with a patented technology for early stage multi-cancer detection seeks investors.
7.2   Singapore
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 13 Mn for 10%
Contact Business
List your business on SMERGERS.
Get visibility from 110,000+ member network of Businesses, Investors, Acquirers, Lenders and Advisors from 900+ Industries and 170+ Countries
Create Business Profile

Bio Diagnostics Company Equity Stake For Sale in Gurugram, India

Med-tech R&D company with a patented technology for early stage multi-cancer detection seeks investors.
The company has pioneered the first blood-based cancer detection tests capable of identifying up to 30 common cancers. - We have consistently focused on innovative solutions for early-stage cancer detection to significantly reduce cancer-related deaths. - The company employs an ingenious approach that combines cutting-edge experimental tools with the latest advancements in deep learning methodologies. - With the global rise in cancer incidence, annual cancer deaths have also increased significantly. - Most cancers are diagnosed at late stages due to the absence of early clinical symptoms, leading to poor prognosis. - Early detection of cancer can reduce mortality by up to 70%, yet no current methods accurately detect cancer at early stages. - We have leveraged this opportunity by developing a groundbreaking blood test that detects 30 cancers in both males and females. - Our product integrates molecular mapping of the physiological state with a deep learning platform to identify cancer-specific molecular signatures. - The test is a novel, non-invasive blood-based screening method capable of detecting cancers and identifying the tissue of origin from the same sample. - The 30 cancers detected represent about 90% of new cancer cases each year. - Our test has achieved an unmatched accuracy of over 98% for early-stage cancer detection. - This advancement can significantly reduce the global cancer mortality burden. - The company is in the process of commercializing the test. - The promoter have over 40+ years of experience in the industry. - Licenses include CIN, SSM and GST. We have also applied for a USFDA. We have applied to the DCGI (Drugs Controller General of India) for market approval in India. We will launch operations post the DCGI approval. - Our target audience includes hospitals in India and Singapore. - Our R&D headquarters are in Haryana, with global headquarters in Singapore. - We also maintain an office in Singapore with dedicated staff.
Med-tech R&D company with a patented technology for early stage multi-cancer detection seeks investors.
7.2   Singapore
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 13 Mn for 10%
Contact Business

Bio Diagnostics Business Equity Stake For Sale in Pune, India

Variety of diagnostic kits for healthcare, infertility, drones, agriculture, food, ngs, research and biotechnology.
Our company is essentially a biotechnology organization that sells proprietary diagnostic kits for healthcare and biotechnology research kits along with services. - These kits allow our customers to evaluate various parameters by themselves. - We have more than 40 in-house researched products. Manufacturing is done at our own premises. - Our products are sold to 32 distributors who further sell them at pharmacies and hospitals across India. Kits are also sold in Saudi Arabia, Dubai, Ukraine, Sudan and Zimbabwe. We do not sell our products directly to any customers. - Revenue plummeted this year due to the effect of the pandemic on the market. - The business is extremely valuable due to our vast array of products, IP, and enormous growth potential in the future.
Variety of diagnostic kits for healthcare, infertility, drones, agriculture, food, ngs, research and biotechnology.
7.4   Pune
Run Rate Sales
USD 820 thousand
EBITDA Margin
10 - 20 %
Partial Stake Sale
USD 1.05 Mn for 25%
Contact Business

Newly Established Bio Diagnostics Company Seeking Loan in Kathmandu, Nepal

Pre-revenue Nepal’s first tech-integrated skin diagnostic infrastructure and premium B2B wellness platform seeking operational launch.
We are an upcoming distribution company of leading global cosmeceutical and mesoceutical brands in Nepal. - We aim to specialize in bringing highly premium, world-renowned professional skincare and aesthetic products from Europe, including Germany, Spain, France and Korea, to the Nepalese market. - Our products will be supplied exclusively through professional aesthetic channels, including MedSpas, aesthetic clinics, dermatologists, skin specialists, and licensed healthcare practitioners. - All the products are professional-grade and backed by internationally recognized quality certifications, including GMP, ISO, and CE, ensuring high standards of safety, quality, and effectiveness. - These products are widely used globally in safe and effective non-invasive aesthetic treatments and skin care procedures. - In addition to product distribution, we also aim to provide comprehensive training and ongoing professional support to licensed practitioners to help them achieve optimal treatment outcomes. - The business is currently in the pre-revenue stage and is focused on establishing exclusive brand partnerships, building inventory, and expanding its professional distribution network across Nepal. - We aim to achieve annual sales of NPR 1 crore in our first year of operations through strategic expansion across key urban markets and professional aesthetic channels. - Several clinics in Kathmandu have already reported positive client feedback from the sample products, demonstrating strong market demand and growth potential. - The company plans to leverage this early market validation to scale operations nationwide and strengthen its position as a leading supplier of premium cosmeceutical and mesoceutical solutions in Nepal. - Registered as a Pvt Ltd company.
7   Kathmandu
Run Rate Sales
Nil
EBITDA Margin
Nil
Business Loan
USD 9.8 K at 10%
Contact Business

Bio Diagnostic Franchise Opportunity

Enbiosis Biotechnology, 13 Franchisees, Est'd in 2021, London HQ
  • 6000+ Page Views
  • 2000+ Investor Views
Company and product: Enbiosis has developed an advanced artificial intelligence algorithm that analyzes the human gut microbiome and recommends personalized food and supplements to individuals to improve their gut health and address chronic disorders such as gastrointestinal disorders, skin-related disorders, and weight loss issues. - How it works: Patients/customers send their stool samples to any NGS laboratory in their region. Enbiosis takes the raw bacterial DNA data to the local server (to avoid data protection risks) and creates a personalized report, which is sent to patients and, if required, their practitioners within minutes. - Business model: Enbiosis's microbiome test can be sold through practitioners and/or directly to customers, depending on market dynamics. Practitioners can prescribe the test to patients to generate a personalized diet plan, or patients can follow their personalized nutrition guide through the app to improve general well-being and solve their problems. - Main differentiation: Enbiosis is the only clinically proven precision diet technology that claims to address the main cause of chronic disorders. It has conducted three clinical trials and published the results in peer-reviewed journals. Enbiosis's claims are backed by scientific evidence. - The main reason why investors should consider Enbiosis: In recent years, the number of people seeking to address their health problems through alternative methods instead of pharmaceuticals has been increasing. The challenge in alternative medicine is the lack of scientific data. Enbiosis serves as a bridge between alternative medicine and conventional medicine, and there is significant market potential for Enbiosis. For example, Enbiosis has proven the effectiveness of its technology in patients with IBS, who make up about 10% of the population. Offering individuals the opportunity to solve their chronic problems simply by changing their diet within a specific period is something they are interested in and willing to try. - Additionally, investors/distributors can offer a routine follow-up program to check gut health and prevent any kind of diseases, opening the door to long-term recurring revenue. - We have a trade registration certificate to operate.
Enbiosis Biotechnology, 13 Franchisees, Est'd in 2021, London HQ
9.3   Expanding in China
Exp Monthly Sales
USD 200 thousand
Space Required
0 - 80 Sq Ft
Investment Required
USD 67 K
Contact Company

Bio Medical Devices Company for Sale in Chennai, India

Established biomedical device business with expert team and educational partnerships for sale.
Established player in the biomedical devices sector, operating from Chennai with a focus on servicing bio-medical equipment and consultancy services. - Currently employs a dedicated team of 8 skilled professionals committed to excellence in service delivery. - Recognized as one of the top 25 companies with innovative products by the Wadhwani Foundation CEO, highlighting its commitment to quality and innovation. - Signed MOU with VIT University, Vellore, and IITM for internship training programs for students, fostering educational collaboration and real-world experience. - Successfully served over 550 hospitals, showcasing a strong market presence and customer trust. - Maintains strategic partnerships with Original Equipment Manufacturers (OEMs) to ensure seamless device procurement. - The promoter brings 33 years of industry experience, having held key positions in leading hospitals and multinational corporations, enhancing business credibility. - Registered with the Ministry of Corporate Affairs (MCA), ensuring compliance with legal frameworks within the industry.
6.6   Chennai
Run Rate Sales
USD 38 thousand
EBITDA Margin
40 %
Business for Sale
USD 1.57 Mn
Contact Business

Biotechnology Business Assets for Lease in Navi Mumbai, India

For lease: Fully equipped DCGI and USFDA approved 20,000 sq ft clinical research facility.
Clinical research facility for lease, spanning an expansive 20,000 sq ft, located in MIDC Industrial Area. - Fully equipped with advanced research infrastructure including 7 LCMS/MS and multiple deep freezers. - Facility includes more than 70 beds, catering to extensive clinical studies. - Approved by both DCGI and USFDA, ensuring compliance with top global standards. - In-house canteen available, enhancing convenience for long-term research projects. - Tenants have the flexibility to continue the existing business or repurpose the facility for different business ventures. - Property valued at approximately $2.3 million, excluding machinery and furnishings, providing significant value. - Open to infrastructure modifications to suit the lessee's requirements, ensuring versatile utility while maintaining core structure integrity. - The whole facility and the associated assets are completely owned by the business. - The promoter is US-based, but the rest of the directors and business operations are based in Navi Mumbai.
For lease: Fully equipped DCGI and USFDA approved 20,000 sq ft clinical research facility.
7.8   Navi Mumbai
Ownership Duration
10-20 year(s)
Industries
Biotechnology
Yearly Lease Amount
USD 300 K
Contact Business

Biotechnology Company for Sale in Mohali, India

For Sale: Company providing quality biotech training to students.
300 students have registered for the current year. - No. can be increased provided full fledge market franchisees are given. - In the field of biotechnology training we are next to the top-notch leaders. - Promoter has 12-13 years of experience in this industry.
7.5   Mohali
Run Rate Sales
USD 57 thousand
EBITDA Margin
30 - 40 %
Business for Sale
USD 147 K
Contact Business

Biotechnology Business for Sale in Bengaluru, India

For sale: Microbiology, molecular-biology, and biotechnology contract research and testing laboratory, small-scale R&D production.
Located in Bangalore, this biotechnology and microbiology research and training organization specializes in training students and conducting small-scale research and development (R&D) production. - The organization provides hands-on training in biotechnology, microbiology, and DNA/RNA extraction, attracting students, PhD scholars, and startup companies. - Additionally, we offer essential food and water testing services to a diverse client base, including both regular and one-time customers. - With a robust presence in South India, the training institute boasts 20 years of experience and has recently expanded to include microbiology testing services initiated two years ago. - The laboratory collaborates with several small-scale industries throughout Bangalore, enhancing practical exposure for their trainees. - Each month, the institute educates between 20 to 30 students, contributing to the growth of skilled professionals in the biotechnology and microbiology fields. - Renowned for its quality service, the organization maintains a Google listing with a 4.4 rating and holds ISO, GST, and MSME certifications, affirming its commitment to industry standards.
For sale: Microbiology, molecular-biology, and biotechnology contract research and testing laboratory, small-scale R&D production.
6.9   Bengaluru
Run Rate Sales
USD 38 thousand
EBITDA Margin
40 %
Business for Sale
USD 58 K
Contact Business

Bio Therapeutic Drugs Company Equity Stake For Sale in Monaragala, Sri Lanka

Ayurvedic doctor with 30+ years of experience needs a foreign investor for cannabis plantation.
Planning to establish a cannabis plantation to produce anesthetic drugs. - Seeking foreign investors to comply with the local law, which mandates that only foreigners can hold a license for cannabis plantations. - The promoter is an Ayurvedic doctor with 30 years of experience in the industry. - We will be applying for licenses, and only foreigners are eligible to hold them. - Our plan is to establish a cannabis plantation and export cannabis anesthetic drugs through distributors worldwide. - The drugs will be specifically formulated for anesthesia purposes.
6.2   Monaragala
Run Rate Sales
Nil
EBITDA Margin
Nil
Partial Stake Sale
USD 5 Mn for 40%
Contact Business

Biotechnology Company Equity Stake For Sale in Tumkur, India

Global preclinical research company, over 300 clients served, seeks investment for tech upgrades and expansion.
Established as a premier Preclinical Contract Research Organisation, the company is GLP certified and ISO/IEC 17025:2017 accredited, ensuring high standards of quality. - Over the past decade, the company has successfully served over 300 clients, demonstrating a solid track record in the preclinical research sector with a focus on global markets. - Revenue generation is driven by conducting specialized studies on clients' products, showcasing the organisation's expertise and relevance in the current market. The profit margins are varying and constantly growing. - The firm boasts a diverse client base spread across the globe, highlighting its capability to meet international research demands and compliance standards. - The company holds prestigious AAALAC International and NABL certifications. - Promoted and led by a team of qualified professionals with robust experience in the industry. - Located in Tumkur, the organisation employs a skilled workforce of 120, combining local talent with global research best practices to deliver exceptional service.
Global preclinical research company, over 300 clients served, seeks investment for tech upgrades and expansion.
8   Tumkur
Run Rate Sales
USD 770 thousand
EBITDA Margin
Nil
Partial Stake Sale
USD 1.3 Mn for 5%
Contact Business

Bio Therapeutic Drugs Company Equity Stake For Sale in Bengaluru, India

Business with bioactive based naturally inspired product, for home & hygiene, intimate care, mosquito/insect repellents.
25 B2B clients in India and 2 abroad. Products available on 5 D2C e-com platforms. We have adopted a cash and carry model with franchises/channel partners in major states and cities.
8.1   Bengaluru
Run Rate Sales
USD 190 thousand
EBITDA Margin
25 %
Partial Stake Sale
USD 260 K for 20%
Contact Business

Bio Therapeutic Drugs Company Equity Stake For Sale in Thiruvananthapuram, India

Kerala-based biotech company developing bioactive formulations, research services, and sustainable life science products.
Client base: Served a wide range of B2B and B2C clients, including corporates, institutions, and individual customers during the COVID-19 period through sanitizer supply. - Currently working with multiple researchers, organizations, and academic institutions for product formulation, outsourcing works, and collaborative projects. - Revenue model: Product sales – Revenue from biotech-based products (e. g. , sanitizers, organic formulations). Services – Income from outsourcing works, product formulation contracts, and collaborative R&D. Training & projects – Fees from student training programs and academic project guidance in biotechnology and life sciences. We get about INR 3-6 lakh of monthly revenue from the services mentioned above. - Promoter experience: The business is led by promoters with strong academic and professional backgrounds in biotechnology research, product development, and laboratory management, with proven expertise in collaborations and student mentorship. - Business relationships: Established strong collaborations with researchers, universities, and organizations for outsourcing projects, technology development, and training initiatives. - Business has a certificate of incorporation and GST certificate. - Awards & Recognition: Mockingjay Award. IVAEX Women’s Day Award. Recognized for contributions during COVID-19 through large-scale sanitizer supply. Appreciated by academic institutions for providing consistent training and project opportunities to students.
Kerala-based biotech company developing bioactive formulations, research services, and sustainable life science products.
5.9   Thiruvananthapuram
Run Rate Sales
USD 50 thousand
EBITDA Margin
10 %
Partial Stake Sale
USD 520 K for 25%
Contact Business

Investing in Businesses: A Comprehensive Guide

Investing in businesses is a strategic endeavor that can significantly grow your wealth if approached knowledgeably. Whether you're a seasoned investor or just starting, understanding the intricacies of businesses for investment is crucial.

Understanding Business Investment

Business investment refers to the allocation of capital to a company with the expectation of receiving financial returns. This can occur through direct investment in a private company or by purchasing stocks and shares of publicly traded businesses.

Types of Business Investments

  1. Equity Investment: This involves purchasing shares of a company. Equity investors become partial owners and have potential returns through dividends and appreciation of the stock value.

  2. Debt Investment: Investors lend money to businesses in exchange for interest income. This can include corporate bonds or business loans.

  3. Venture Capital and Angel Investing: These are types of equity investment where investors provide capital to startups and small businesses that have potential for growth.

  4. Crowdfunding: An innovative way to invest in businesses where multiple investors contribute small amounts of capital via platforms like Kickstarter or Indiegogo.

Advantages of Investing in Businesses

  • Potential for High Returns: Businesses have the potential to grow substantially, resulting in significant returns on investment.
  • Portfolio Diversification: Investing in various businesses can diversify an investment portfolio, reducing overall risk.
  • Active Involvement: Investors can actively participate in their investments, offering guidance and support to businesses.

Risks Involved in Business Investment

Even though investing in businesses offers attractive returns, it involves certain risks:

  • Market Volatility: Economic changes can affect business profitability and stock prices.
  • Failure Risk: Especially with startups, there's always a risk of failure resulting in loss of investment.
  • Regulatory Issues: Changes in laws and regulations can impact businesses adversely.

How to Choose the Right Business for Investment

  • Research and Analysis: Understand the business model, industry sector, and financial health of the business.
  • Growth Potential: Evaluate the business's potential for growth and scalability.
  • Management Quality: A competent management team can greatly influence a business’s success.
  • Market Trends: Stay updated with market trends and economic conditions that might affect the business.
  • Competitive Advantage: Ensure the business has a unique selling proposition or competitive edge.

Conclusion

Investing in businesses for investment can be incredibly rewarding. However, it requires a thorough understanding of the market, diligent research, and careful selection. By weighing the potential benefits against the risks and conducting due diligence, investors can enhance their ability to make profitable investments. Always consider consulting a financial advisor to tailor your investment strategy to your personal financial goals and risk tolerance.

Invest wisely, and watch your investments flourish!

Frequently
Asked
Questions
  • How many businesses for sale and investment are listed on SMERGERS?
    There are 23887 active and verified businesses for sale and investment listed on SMERGERS as of 07 August 2026.
  • What level of due diligence does SMERGERS conduct on the businesses/member?

    SMERGERS scrutinizes all profiles and only features a select group of businesses, investors, advisors that meet a basic requirement. When required, certain members may have submitted some form of proof …read more

  • How active are the business profiles listed on SMERGERS?

    We regularly filter out businesses which are inactive or have already closed a transaction. Typically, if the business is actively looking to sell/raise capital, the status is shown in green.

  • How can I be sure about privacy and confidentiality?

    We understand the level of confidentiality required in strategic transactions and we strive to provide a safe and secure experience for our members. Please review our privacy policy. We …read more

  • How can I contact a business listed on SMERGERS?

    You need to be logged in before you connect with a business. Click here to register and message the business If you are already logged in, please use the contact …read more

  • Should you buy an existing business or start a business from scratch?

    Buying an existing business is generally an easier way to start a business with an immediate head start. It saves valuable time and administrative efforts, considering starting from scratch is …read more

  • How successful has SMERGERS been in helping its users successfully close a deal?

    SMERGERS is a discovery and matchmaking platform with a global reach. It helps in connecting Businesses, Investors, Acquirers, Lenders, M&A Advisors and Boutique Investment Banks across locations, industries and transactions. …read more

  • Show more

Chat with Us
Welcome to SMERGERS